These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8834978)

  • 1. Lipid profiles and blood pressure: are they risk factors for the development of early background retinopathy and incipient nephropathy in children with insulin-dependent diabetes mellitus?
    Kordonouri O; Danne T; Hopfenmüller W; Enders I; Hövener G; Weber B
    Acta Paediatr; 1996 Jan; 85(1):43-8. PubMed ID: 8834978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal and retinal microangiopathy after 15 years of follow-up study in a sample of Type 1 diabetes mellitus patients.
    Romero P; Salvat M; Fernández J; Baget M; Martinez I
    J Diabetes Complications; 2007; 21(2):93-100. PubMed ID: 17331857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
    Agardh CD; Agardh E; Torffvit O
    Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of prorenin values to microvascular complications in patients with insulin-dependent diabetes mellitus.
    Davies L; Fulcher GR; Atkins A; Frumar K; Monaghan J; Stokes G; Clifton-Bligh P; McElduff A; Robinson B; Stiel J; Twigg S; Wilmshurst E
    J Diabetes Complications; 1999; 13(1):45-51. PubMed ID: 10232709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between plasma triglycerides and high-density lipoprotein cholesterol and microvascular kidney disease and retinopathy in type 2 diabetes mellitus: a global case-control study in 13 countries.
    Sacks FM; Hermans MP; Fioretto P; Valensi P; Davis T; Horton E; Wanner C; Al-Rubeaan K; Aronson R; Barzon I; Bishop L; Bonora E; Bunnag P; Chuang LM; Deerochanawong C; Goldenberg R; Harshfield B; Hernández C; Herzlinger-Botein S; Itoh H; Jia W; Jiang YD; Kadowaki T; Laranjo N; Leiter L; Miwa T; Odawara M; Ohashi K; Ohno A; Pan C; Pan J; Pedro-Botet J; Reiner Z; Rotella CM; Simo R; Tanaka M; Tedeschi-Reiner E; Twum-Barima D; Zoppini G; Carey VJ
    Circulation; 2014 Mar; 129(9):999-1008. PubMed ID: 24352521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations and interactions between lipid profiles, retinopathy and nephropathy in patients with type 1 diabetes: the FinnDiane Study.
    Tolonen N; Hietala K; Forsblom C; Harjutsalo V; Mäkinen VP; Kytö J; Summanen PA; Thorn LM; Wadén J; Gordin D; Taskinen MR; Groop PH;
    J Intern Med; 2013 Nov; 274(5):469-79. PubMed ID: 23844944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen and von Willebrand factor in IDDM: relationships to lipid vascular risk factors, blood pressure, glycaemic control and urinary albumin excretion rate: the EURODIAB IDDM Complications Study.
    Greaves M; Malia RG; Goodfellow K; Mattock M; Stevens LK; Stephenson JM; Fuller JH
    Diabetologia; 1997 Jun; 40(6):698-705. PubMed ID: 9222650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of renal morphological changes in the early stage of microalbuminuria in adolescents with IDDM.
    Rudberg S; Osterby R; Dahlquist G; Nyberg G; Persson B
    Diabetes Care; 1997 Mar; 20(3):265-71. PubMed ID: 9051369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HbA
    Lind M; Pivodic A; Svensson AM; Ólafsdóttir AF; Wedel H; Ludvigsson J
    BMJ; 2019 Aug; 366():l4894. PubMed ID: 31462492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study.
    Coonrod BA; Ellis D; Becker DJ; Bunker CH; Kelsey SF; Lloyd CE; Drash AL; Kuller LH; Orchard TJ
    Diabetes Care; 1993 Oct; 16(10):1376-83. PubMed ID: 8269796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
    Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
    Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between HbA1c Variability and Risk of Microvascular Complications in Adolescents With Type 1 Diabetes.
    Virk SA; Donaghue KC; Cho YH; Benitez-Aguirre P; Hing S; Pryke A; Chan A; Craig ME
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3257-63. PubMed ID: 27186858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of borderline increases in albuminuria in adolescents with insulin-dependent diabetes mellitus.
    Couper JJ; Clarke CF; Byrne GC; Jones TW; Donaghue KC; Nairn J; Boyce D; Russell M; Stephens M; Raymond J; Bates DJ; McCaul K
    Diabet Med; 1997 Sep; 14(9):766-71. PubMed ID: 9300227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM.
    Rudberg S; Persson B
    Diabetes Care; 1995 Jul; 18(7):933-9. PubMed ID: 7555552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid Biomarkers as Predictors of Diastolic Dysfunction in Diabetes with Poor Glycemic Control.
    Khedr D; Hafez M; Lumpuy-Castillo J; Emam S; Abdel-Massih A; Elmougy F; Elkaffas R; Mahillo-Fernández I; Lorenzo O; Musa N
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycaemic control and familial factors determine hyperlipidaemia in early childhood diabetes. Oxford Regional Prospective Study of Childhood Diabetes.
    Abraha A; Schultz C; Konopelska-Bahu T; James T; Watts A; Stratton IM; Matthews DR; Dunger DB
    Diabet Med; 1999 Jul; 16(7):598-604. PubMed ID: 10445837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal involvement in type 1 (IDDM) diabetes in Spain. ESTUDIO DIAMANTE.
    Diabetes Res Clin Pract; 1997 Nov; 38(2):129-37. PubMed ID: 9483377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes.
    Hadjadj S; Duly-Bouhanick B; Bekherraz A; BrIdoux F; Gallois Y; Mauco G; Ebran J; Marre M
    Diabetes Metab; 2004 Feb; 30(1):43-51. PubMed ID: 15029097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
    Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
    Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concordance of retinopathy and nephropathy over time in Type 1 diabetes: an analysis of data from the Diabetes Control and Complications Trial.
    Kramer CK; Retnakaran R
    Diabet Med; 2013 Nov; 30(11):1333-41. PubMed ID: 23909911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.